81 related articles for article (PubMed ID: 12450424)
1. Clinical colorectal cancer: thymidylate synthase as a molecular biomarker.
Chu E
Clin Colorectal Cancer; 2001 Nov; 1(3):136-7. PubMed ID: 12450424
[No Abstract] [Full Text] [Related]
2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the thymidylate synthase gene predict response to 5-fluorouracil therapy in colorectal cancer.
Gibson TB
Clin Colorectal Cancer; 2006 Jan; 5(5):321-3. PubMed ID: 16512989
[No Abstract] [Full Text] [Related]
4. Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil.
Negri FV; Azzoni C; Bottarelli L; Campanini N; Mandolesi A; Wotherspoon A; Cunningham D; Scartozzi M; Cascinu S; Tinelli C; Silini EM; Ardizzoni A
Anticancer Res; 2013 Oct; 33(10):4611-7. PubMed ID: 24123038
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment.
Trocha SD; Saha SS; Wiese D; Thompson J; Morton DL; Bilchik AJ
Am Surg; 2003 Oct; 69(10):918-22. PubMed ID: 14570375
[TBL] [Abstract][Full Text] [Related]
6. Cancer chronotherapy: principles, applications, and perspectives.
Vincenzi B; Santini D; La Cesa A; Tonini G
Cancer; 2003 Aug; 98(4):881-2; author reply 882-3. PubMed ID: 12910534
[No Abstract] [Full Text] [Related]
7. Thymidylate synthase levels in tumor biopsies from patients with colorectal cancer.
Mulder NH; Timmer-Bosscha H; Meersma GJ; Verschueren RC
Anticancer Res; 1994; 14(6B):2677-80. PubMed ID: 7872700
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
Ren DN; Kim IY; Koh SB; Chang SJ; Eom M; Yi SY; Seong SH; Kim MD; Bronner MP; Cho MY
J Surg Oncol; 2009 Dec; 100(7):546-52. PubMed ID: 19722231
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase and capecitabine: a predictive marker for therapy selection?
O'Neil BH; McLeod HL
J Clin Oncol; 2006 Sep; 24(25):4051-3. PubMed ID: 16943521
[No Abstract] [Full Text] [Related]
11. Thymidylate synthase gene expression in primary colorectal cancer and metastatic sites.
Yamada H; Ichikawa W; Uetake H; Shirota Y; Nihei Z; Sugihara K; Hirayama R
Clin Colorectal Cancer; 2001 Nov; 1(3):169-73; discussion 174. PubMed ID: 12450430
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of thymidylate synthase, p16(INK4a), cyclin-dependent kinase 4 and cyclin D1 in colorectal cancers receiving preoperative chemotherapy: significance of p16(INK4a)-mediated cellular arrest as an indicator of chemosensitivity to 5-fluorouracil.
Kamoshida S; Matsuoka H; Shiogama K; Matsuyama A; Shimomura R; Inada K; Maruta M; Tsutsumi Y
Pathol Int; 2004 Aug; 54(8):564-75. PubMed ID: 15260847
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
[TBL] [Abstract][Full Text] [Related]
14. Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data.
Chazal M; Cheradame S; Formento JL; Francoual M; Formento P; Etienne MC; François E; Richelme H; Mousseau M; Letoublon C; Pezet D; Cure H; Seitz JF; Milano G
Clin Cancer Res; 1997 Apr; 3(4):553-7. PubMed ID: 9815719
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase pharmacogenetics in colorectal cancer.
Marsh S; McLeod HL
Clin Colorectal Cancer; 2001 Nov; 1(3):175-8; discussion 179-81. PubMed ID: 12450432
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracil.
Fernández-Contreras ME; Sánchez-Prudencio S; Sánchez-Hernández JJ; García de Paredes ML; Gisbert JP; Roda-Navarro P; Gamallo C
Int J Oncol; 2006 May; 28(5):1303-10. PubMed ID: 16596248
[TBL] [Abstract][Full Text] [Related]
17. Correlation between thymidylate synthase protein expression and gene polymorphism with clinicopathological parameters in colorectal carcinoma.
Moreira LR; Schenka AA; Latuff Filho P; Nascimento H; Passos Lima CS; Silva Trevisan MA; Vassallo J
Int J Surg Pathol; 2009 Jun; 17(3):181-6. PubMed ID: 19147506
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy.
Santini D; Vincenzi B; Perrone G; Rabitti C; Borzomati D; Caricato M; La Cesa A; Grilli C; Verzì A; Coppola R; Tonini G
Oncology; 2004; 67(2):135-42. PubMed ID: 15539918
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil.
Aschele C; Debernardis D; Tunesi G; Maley F; Sobrero A
Clin Cancer Res; 2000 Dec; 6(12):4797-802. PubMed ID: 11156237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
